A 2022 case series in Pharmacotherapy (Davidson et al.) reported INR fluctuations in 6 of 9 warfarin patients starting semaglutide, requiring dose adjustments ranging from 15% reduction to 25% increase
It includes: One-on-one physician consultation Ongoing monthly clinical oversight and provider support Access to compounded GLP-1/GIP injections (if medically appropriate) Monthly medication supply from a licensed compounding pharmacy Optional wellness add-ons: lab testing, nutritional guidance, and more *Program starts at $400/month Who May Qualify This program may be appropriate for individuals who: Have a BMI of 30+, or 27+ with a related health condition Have not achieved success with other weight loss methods May not be candidates for brand-name GLP-1/GIP medications Want a clinically guided, structured approach to weight loss A thorough medical consultation will determine your eligibility and treatment plan

Safety Advantage: Astaxanthin+ by Innerbody Labs Astaxanthin is generally well-tolerated in healthy adults, with clinical studies showing no serious side effects at doses up to 24mg per day for extended periods.11 Most supplements provide between 4mg and 12mg daily well within the range confirmed safe in human trials and safety reviews
A More Modern Approach to Weight Management This program uses a compounded semaglutide formulation combined with B-12 and glycine, delivered as part of a provider-reviewed care plan
Next, we selected a concentration of 50 M HT and a treatment duration of 9 h for the subsequent experiments (Fig